Title |
Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
|
---|---|
Published in |
Annals of Clinical Microbiology and Antimicrobials, September 2006
|
DOI | 10.1186/1476-0711-5-23 |
Pubmed ID | |
Authors |
Asma Marzouq Al-Jasser |
Abstract |
Stenotrophomonas maltophilia (S. maltophilia) has recently emerged as an important nosocomial pathogen. Treatment of invasive infections caused by this organism is difficult as the bacterium is frequently resistant to a wide range of commonly used antimicrobials. Trimethoprim-sulfamethoxazole (TMP - SXT) is recommended as the agent of choice for the treatment of S. maltophilia infections. However, the development of resistance to this antibiotic represents a real challenge to laboratorians and clinicians. This letter describes the first isolation of S. maltophilia resistant to TMP - SXT from two patients treated at Riyadh Armed Forces Hospital which is a major tertiary hospital in Saudi Arabia. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 2 | 1% |
Ghana | 1 | <1% |
Montenegro | 1 | <1% |
Brazil | 1 | <1% |
Mexico | 1 | <1% |
Unknown | 140 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 22 | 15% |
Student > Master | 22 | 15% |
Student > Ph. D. Student | 21 | 14% |
Student > Bachelor | 12 | 8% |
Student > Postgraduate | 12 | 8% |
Other | 36 | 25% |
Unknown | 21 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 46 | 32% |
Agricultural and Biological Sciences | 34 | 23% |
Immunology and Microbiology | 15 | 10% |
Biochemistry, Genetics and Molecular Biology | 8 | 5% |
Veterinary Science and Veterinary Medicine | 6 | 4% |
Other | 13 | 9% |
Unknown | 24 | 16% |